Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Discovery
Sponsor : Eli Lilly
Deal Size : Undisclosed
Deal Type : Collaboration
5 Prime Sciences Announces Strategic Collaboration with Lilly in Cardio-Metabolic Diseases
Details : Under the collaboration, 5 Prime Sciences will utilize its advanced human genetics and AI technologies to identify and validate potential drug targets for cardio-metabolic diseases & diabetes.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
May 09, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Discovery
Sponsor : Eli Lilly
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?